Efficacy and safety of intra-arterial thrombolysis in central retinal artery occlusion

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 12, 2013, Pages 7746-7755

  Ahn, Seong Joon ^a   Kim, Jae Min ^a   Hong, Jeong Ho ^a   Woo, Se Joon ^a   Ahn, Jeeyun ^b   Park, Kyu Hyung ^a   Han, Moon Ku ^a   Jung, Cheolkyu ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University Boramae Hospital   (South Korea)

Author keywords

Central retinal artery occlusion; Intra arterial thrombolysis; Outcome; Reperfusion

Indexed keywords

ACETAZOLAMIDE; ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; TIMOLOL; UROKINASE;

ADULT; AGED; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CENTRAL RETINA ARTERY OCCLUSION; CEREBROVASCULAR ACCIDENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DETERIORATION; DRUG EFFICACY; DRUG SAFETY; EYE EDEMA; EYE FUNDUS; FEMALE; FUNDUS CAMERA; HEADACHE; HEMATOMA; HEMIANOPIA; HUMAN; HYPERESTHESIA; INFARCTION; INTRAOCULAR PRESSURE; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; NEOVASCULAR GLAUCOMA; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOSCOPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REPERFUSION; REVIEW; SIDE EFFECT; TINNITUS; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; VISUAL ACUITY;

CENTRAL RETINAL ARTERY OCCLUSION; INTRA-ARTERIAL THROMBOLYSIS; OUTCOME; REPERFUSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; INJECTIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; OPHTHALMIC ARTERY; RETINA; RETINAL ARTERY OCCLUSION; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; VISUAL ACUITY; YOUNG ADULT;

EID: 84888101267     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12952     Document Type: Review

References (42)

1. Arnold M, Koerner U, Remonda L, et al. Comparison of intraarterial thrombolysis with conventional treatment in patients with acute central retinal artery occlusion. J Neurol Neurosurg Psychiatry. 2005;76:196-199.
2. Augsburger JJ, Magargal LE. Visual prognosis following treatment of acute central retinal artery obstruction. Br J Ophthalmol. 1980;64:913-917.
3. Brown GC, Magargal LE. Central retinal artery obstruction and visual acuity. Ophthalmology. 1982;89:14-19.
4. Arruga J, Sanders MD. Ophthalmologic findings in 70 patients with evidence of retinal embolism. Ophthalmology. 1982;89:1336-1347.
5. Atebara NH, Brown GC, Cater J. Efficacy of anterior chamber paracentesis and Carbogen in treating acute nonarteritic central retinal artery occlusion. Ophthalmology. 1995;102:2029-2034;discussion 2025-2034.
6. Mueller AJ, Neubauer AS, Schaller U, Kampik A. Evaluation of minimally invasive therapies and rationale for a prospective randomized trial to evaluate selective intra-arterial lysis for clinically complete central retinal artery occlusion. Arch Ophthalmol. 2003;121:1377-1381.
7. Rumelt S, Brown GC. Update on treatment of retinal arterial occlusions. Curr Opin Ophthalmol. 2003;14:139-141.
8. Schmidt DP, Schulte-Monting J, Schumacher M. Prognosis of central retinal artery occlusion: local intraarterial fibrinolysis versus conservative treatment. AJNR Am J Neuroradiol. 2002;23:1301-1307.
9. Schmidt D, Schumacher M. Stage-dependent efficacy of intraarterial fibrinolysis in central retinal artery occlusion (CRAO). Neuroophthalmology. 1998;20:125-141.
10. Aisenbrey S, Krott R, Heller R, Krauss D, Rossler G, Heimann K. Hyperbaric oxygen therapy in retinal artery occlusion [in German]. Ophthalmologe. 2000;97:461-467.
11. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:483S-512S.
12. Beiran I, Goldenberg I, Adir Y, Tamir A, Shupak A, Miller B. Early hyperbaric oxygen therapy for retinal artery occlusion. Eur J Ophthalmol. 2001;11:345-350.
13. Ffytche TJ. A rationalization of treatment of central retinal artery occlusion. Trans Ophthalmol Soc U K. 1974;94:468-479.
14. Ffytche TJ, Bulpitt CJ, Kohner EM, Archer D, Dollery CT. Effect of changes in intraocular pressure on the retinal microcirculation. Br J Ophthalmol. 1974;58:514-522.
15. Fraser SG, Adams W. Interventions for acute non-arteritic central retinal artery occlusion. Cochrane Database Syst Rev. 2009;CD001989.
16. Garcia-Arumi J, Martinez-Castillo V, Boixadera A, Fonollosa A, Corcostegui B. Surgical embolus removal in retinal artery occlusion. Br J Ophthalmol. 2006;90:1252-1255.
17. Gombos GM. Anterior chamber paracentesis and carbogen treatment of acute CRAO. Ophthalmology. 1996;103:865.
18. Hausmann N, Richard G. Effect of high dose steroid bolus on occlusion of ocular central artery: angiographic study. BMJ. 1991;303:1445-1446.
19. Incandela L, Cesarone MR, Belcaro G, et al. Treatment of vascular retinal disease with pentoxifylline: a controlled, randomized trial. Angiology. 2002;53(suppl 1);S31-S34.
20. Magargal LE, Goldberg RE. Anterior chamber paracentesis in the management of acute nonarteritic central retinal artery occlusion. Surg Forum. 1977;28:518-521.
21. Rufer F, Schroder A, Winter R, Erb C. Analysis of risk factors and comparison of heparin and hemodilution therapies for retinal artery occlusion [in German]. Ophthalmologe. 2003;100:819-824.
22. Rumelt S, Dorenboim Y, Rehany U. Aggressive systematic treatment for central retinal artery occlusion. Am J Ophthalmol. 1999;128:733-738.
23. Steigerwalt RD Jr, Pescosolido N, Corsi M, Cesarone MR, Belcaro GV. Acute branch retinal arterial embolism successfully treated with intravenous prostaglandin E1-case reports. Angiology. 2003;54:491-493.
24. Weinberger AW, Siekmann UP, Wolf S, Rossaint R, Kirchhof B, Schrage NF. Treatment of acute central retinal artery occlusion (CRAO) by hyperbaric oxygenation therapy (HBO)-pilot study with 21 patients [in German]. Klin Monbl Augenheilkd. 2002;219:728-734.
25. Chen CS, Lee AW, Campbell B, et al. Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial. Stroke. 2011;42:2229-2234.
26. Biousse V, Calvetti O, Bruce BB, Newman NJ. Thrombolysis for central retinal artery occlusion. J Neuroophthalmol. 2007;27:215-230.
27. Noble J, Weizblit N, Baerlocher MO, Eng KT. Intra-arterial thrombolysis for central retinal artery occlusion: a systematic review. Br J Ophthalmol. 2008;92:588-593.
28. Richard G, Lerche RC, Knospe V, Zeumer H. Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator. Ophthalmology. 1999;106:768-773.
29. Schmidt D, Schumacher M, Wakhloo AK. Microcatheter urokinase infusion in central retinal artery occlusion. Am J Ophthalmol. 1992;113:429-434.
30. Schumacher M, Schmidt D, Jurklies B, et al. Central retinal artery occlusion: local intra-arterial fibrinolysis versus conser-vative treatment, a multicenter randomized trial. Ophthalmology. 2010;117:1367-1375.
31. Weber J, Remonda L, Mattle HP, et al. Selective intra-arterial fibrinolysis of acute central retinal artery occlusion. Stroke. 1998;29:2076-2079.
32. Weill A, Cognard C, Piotin M, Laloum L, Castaings L, Moret J. Persistent value of intra-arterial fibrinolysis 8 hours or more following central retinal artery occlusion or of its branches [in French]. J Fr Ophtalmol. 1998;21:466-470.
33. Schumacher M, Schmidt D, Wakhloo AK. Intra-arterial fibrinolytic therapy in central retinal artery occlusion. Neuroradiology. 1993;35:600-605.
34. Beatty S, Au Eong KG. Local intra-arterial fibrinolysis for acute occlusion of the central retinal artery: a meta-analysis of the published data. Br J Ophthalmol. 2000;84:914-916.
35. Lange C, Feltgen N, Junker B, Schulze-Bonsel K, Bach M. Resolving the clinical acuity categories "hand motion" and "counting fingers" using the Freiburg Visual Acuity Test (FrACT). Graefes Arch Clin Exp Ophthalmol. 2009;247:137-142.
36. David NJ, Saito Y, Heyman A. Arm to retina fluorescein appearance time. A new method of diagnosis of carotid artery occlusion. Arch Neurol. 1961;5:165-170.
37. Bjarnhall G, Maepea O, Sperber GO, Linden C, Monestam E, Alm A. Analysis of mean retinal transit time from fluorescein angiography in human eyes: normal values and reproducibility. Acta Ophthalmol Scand. 2002;80:652-655.
38. Hayreh SS, Kolder HE, Weingeist TA. Central retinal artery occlusion and retinal tolerance time. Ophthalmology. 1980;87:75-78.
39. Toni D, Fiorelli M, Bastianello S, et al. Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology. 1996;46:341-345.
40. Arthur A, Aaron S. Thrombolysis for artery occlusion. Ophthalmology. 2011;118:604;author reply 604-605.
41. Bendszus M, Koltzenburg M, Burger R, Warmuth-Metz M, Hofmann E, Solymosi L. Silent embolism in diagnostic cerebral angiography and neurointerventional procedures: a prospective study. Lancet. 1999;354:1594-1597.
42. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215-1222.